Diagnostic Value of Changes in Serum Calprotectin Level and Patients' Sputum in Response to Treatment of Cystic Fibrosis Exacerbation in Children
Diagnostic Value of Changes in Serum Calprotectin Level and Patients' Sputum in Response to Treatment of Cystic Fibrosis Exacerbation in Children
نویسندگان: نعمت بیلان , فریناز امیری کار , سینا رئیسی
کلمات کلیدی: Calprotectin, Cystic fibrosis, Exacerbation, Iran, Therapeutic outcome.
نشریه: 37721 , 5 , 9 , 2021
| نویسنده ثبت کننده مقاله |
نعمت بیلان |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات سلامت کودکان |
| کد مقاله |
76241 |
| عنوان فارسی مقاله |
Diagnostic Value of Changes in Serum Calprotectin Level and Patients' Sputum in Response to Treatment of Cystic Fibrosis Exacerbation in Children |
| عنوان لاتین مقاله |
Diagnostic Value of Changes in Serum Calprotectin Level and Patients' Sputum in Response to Treatment of Cystic Fibrosis Exacerbation in Children |
| ناشر |
3 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Background
Today few studies have focused on using calprotectin as an effective biomarker for monitoring the
exacerbation of pulmonary complications in cystic fibrosis (CF). Thus, the present study aimed to
assess the diagnostic value of the changes in the calprotectin level of patient's serum and sputum
during responding to the therapy of exacerbated CF in children.
Materials and Methods: The cross-sectional study was conducted among 21 CF patients, which
received required supportive and therapeutic procedures based on the protocol related to pulmonology
ward in the Children Medical Research and Training Center of Tabriz University of Medical Sciences.
The sputum and serum samples of all patients were collected to evaluate calprotectin level at 1-2 days
after starting therapy with routine antibiotics such as cephalosporin and macrolides, and they were
again gathered at the end of therapy process.
Results: Assessing outcome in 21 patients under study represented complete and partial recovery in
12 (57.2%), and 9 (42.8%) ones, respectively. The mean decrease in calprotectin level in the serum
and sputum of the patients was respectively obtained as 40.72 89.08 μg/ml and 99.03 225.94 μg/ml.
The calprotectin decrease in serum with the cutoff point of 15.70 μg/ml possessed the sensitivity of
66.7% and specificity of 55.6% in predicting complete recovery outcome; while that of sputum with
the cutoff point of 26.20 μg/ml had the sensitivity and specificity of 66.7 and 22.2%, respectively.
Conclusion
The mean age of participants were 8.61±4.19 years. It can be concluded that serum and sputum
calprotectin decrease with cutoff point of 15.70 μg/ml and 26.20 μg/ml, respectively in have high
sensitivity for determining response to treatment in cystic fibrosis exacerbation. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| IJP_Volume 9_Issue 5_Pages 13569-13579 (1).pdf | 1400/04/14 | 387155 | دانلود |